Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction
- PMID: 24993487
- PMCID: PMC4589411
- DOI: 10.1016/j.contraception.2014.05.015
Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction
Abstract
Objectives: Develop and test a theoretical acceptability model for the Nestorone®/ethinyl estradiol contraceptive vaginal ring (CVR); explore whether domains of use within the model predict satisfaction, method adherence and CVR continuation.
Study design: Four domains of use were considered relative to outcome markers of acceptability, that is, method satisfaction, adherence and continuation. A questionnaire to evaluate subjects' experiences relative to the domains, their satisfaction (Likert scale) and adherence to instructions for use was developed and administered to 1036 women enrolled in a 13-cycle Phase 3 trial. Method continuation was documented from the trial database. Stepwise logistic regression (LR) analysis was conducted and odds ratios (ORs) calculated to assess associations of satisfaction with questions from the four domains. Fisher's Exact Test was used to determine the association of satisfaction with outcome measures.
Results: A final acceptability model was developed based on the following determinants of CVR satisfaction: ease of use, side effects, expulsions/feeling the CVR and sexual activity including physical effects during intercourse. Satisfaction was high (89%) and related to higher method adherence [OR, 2.6 (1.3, 5.2)] and continuation [OR, 5.5 (3.5, 8.4)]. According to the LR analysis, attributes of CVR use representing items from the four domains - finding it easy to remove, not complaining of side effects, not feeling the CVR while wearing it and experiencing no change or an increase in sexual pleasure and/or frequency - were associated with higher odds of satisfaction.
Conclusion: Hypothesized domains of CVR use were related to satisfaction, which was associated with adherence and continuation. Results provide a scientific basis for introduction and future research.
Implications statement: Acceptability research is important when introducing a new method of contraception and determining whether it can be a successful option in meeting the reproductive health needs of women and men. This study was designed to test a conceptual model of acceptability and identify factors associated with successful use of a new contraceptive delivery modality. Original research was conducted for this publication.
Trial registration: ClinicalTrials.gov NCT00263341.
Keywords: Acceptability model; Hormonal contraception; Long-acting delivery system; Method introduction; Vaginal ring.
Copyright © 2014. Published by Elsevier Inc.
Figures
Similar articles
-
Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.Contraception. 2018 May;97(5):415-421. doi: 10.1016/j.contraception.2017.12.011. Epub 2017 Dec 18. Contraception. 2018. PMID: 29269252 Free PMC article. Clinical Trial.
-
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.Contraception. 2016 Jan;93(1):58-64. doi: 10.1016/j.contraception.2015.09.008. Epub 2015 Sep 25. Contraception. 2016. PMID: 26408374 Clinical Trial.
-
Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.Contraception. 2018 Mar;97(3):270-276. doi: 10.1016/j.contraception.2017.10.010. Epub 2017 Oct 31. Contraception. 2018. PMID: 29097225 Clinical Trial.
-
A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year.Expert Opin Drug Deliv. 2020 Jun;17(6):743-752. doi: 10.1080/17425247.2020.1764529. Epub 2020 May 15. Expert Opin Drug Deliv. 2020. PMID: 32410464 Review.
-
Vaginal ring contraception.Contraception. 2011 Feb;83(2):107-15. doi: 10.1016/j.contraception.2010.07.008. Epub 2010 Oct 6. Contraception. 2011. PMID: 21237335 Review.
Cited by
-
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate.Contraception. 2020 Sep;102(3):168-173. doi: 10.1016/j.contraception.2020.05.004. Epub 2020 May 19. Contraception. 2020. PMID: 32416145 Free PMC article. Clinical Trial.
-
A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies.Perspect Sex Reprod Health. 2019 Jun;51(2):71-80. doi: 10.1363/psrh.12103. Epub 2019 May 20. Perspect Sex Reprod Health. 2019. PMID: 31108027 Free PMC article.
-
Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis.Front Glob Womens Health. 2021 Dec 14;2:799963. doi: 10.3389/fgwh.2021.799963. eCollection 2021. Front Glob Womens Health. 2021. PMID: 34970653 Free PMC article. Review.
-
A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies.Int Perspect Sex Reprod Health. 2019 Oct 4;45:25-34. doi: 10.1363/45e7619. Int Perspect Sex Reprod Health. 2019. PMID: 31592770 Free PMC article.
-
Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.Contraception. 2020 Sep;102(3):159-167. doi: 10.1016/j.contraception.2020.04.016. Epub 2020 May 1. Contraception. 2020. PMID: 32360666 Free PMC article. Clinical Trial.
References
-
- Sivin I, Mishell DR, Alvarez F, et al. Contraceptive vaginal rings releasing Nestorone and ethinyl estradiol: a 1-year dose-finding trial. Contraception. 2005;71:122–9. - PubMed
-
- Brache V, Payán LJ, Faundes A. Current status of contraceptive vaginal rings. Contraception. 2013;87(3):264–72. - PubMed
-
- Faundes A, Hardy EE, Reyes Q, et al. Acceptability of the contraceptive vaginal ring by rural and urban populations in two Latin American countries. Contraception. 1981;24:393–414. - PubMed
-
- Darroch J, Sedgh G, Ball H. Contraceptives technologies: Responding to women’s needs. NewYork: Guttmacher Institute; 2011.
-
- Barot S. In search of breakthroughs: Renewing support for contraceptive research and development. Guttmacher Policy Review. 2013 Winter;16(1)
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical